Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Cardiol Rev. 2024;32(4):314-319. doi: 10.1097/CRD.0000000000000508. Epub 2024 Jun 6.
Several vaccines against coronavirus disease 2019 (COVID-19)-caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-have been developed since the COVID-19 pandemic began. Of these, 7 have been approved in the World Health Organization's Emergency Use Listing. However, these vaccines have been reported to have rare or serious adverse cardiovascular effects. This review presents updated information on the adverse cardiovascular effects of the approved COVID-19 vaccines-including inactivated vaccines, protein subunit vaccines, virus-like particles, nucleic acid vaccines, and viral vector vaccines-and the underlying mechanisms.
自 COVID-19 大流行以来，已经开发出了几种针对由新型严重急性呼吸系统综合症冠状病毒-2（SARS-CoV-2）引起的 2019 年冠状病毒病（COVID-19）的疫苗。其中，有 7 种已在世界卫生组织的紧急使用清单中获得批准。然而，这些疫苗被报道具有罕见或严重的不良心血管作用。本综述介绍了已批准的 COVID-19 疫苗（包括灭活疫苗、蛋白亚单位疫苗、病毒样颗粒、核酸疫苗和病毒载体疫苗）的不良心血管作用的最新信息，以及潜在机制。
